Lista de obras - Elisabetta Munzone - Dominio Público Uruguay

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

artículo científico publicado en 2013

Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?

artículo científico publicado en 2012

Brain metastases in patients with advanced breast cancer

artículo científico publicado en 2007

CMF revisited in the 21st century ⬇️

artículo científico publicado el 29 de junio de 2011

Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.

artículo científico publicado en 2006

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

artículo científico publicado en 2010

Clinical overview of metronomic chemotherapy in breast cancer.

artículo científico

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

artículo científico publicado en 2014

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

artículo científico publicado en 2006

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

artículo científico publicado en 2015

Development and psychometric testing of a breast cancer patient-profiling questionnaire

artículo científico publicado en 2015

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

artículo científico publicado en 2013

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

artículo científico publicado en 2016

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

artículo científico publicado en 2014

Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.

artículo científico publicado en 2005

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer.

artículo científico publicado en 2005

Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.

artículo científico publicado en 2001

Extended adjuvant chemotherapy in endocrine non-responsive disease

artículo científico

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives

scientific article published on 18 March 2020

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

artículo científico publicado en 2020

Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)

scientific article published on 01 November 1999

Highlights from the ninth European breast cancer conference, glasgow, 19-21 march 2014

artículo científico publicado en 2014

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

artículo científico publicado en 2014

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

artículo científico publicado en 2015

Metronomic therapy and breast cancer: a systematic review.

artículo científico publicado en 2014

Metronomics in the neoadjuvant and adjuvant treatment of breast cancer

artículo científico publicado en 2017

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

artículo científico publicado en 2009

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

artículo científico publicado en 2018

Mutations targeting the coagulation pathway are enriched in brain metastases.

artículo científico publicado en 2017

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer

artículo científico

Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination

artículo científico publicado en 2007

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

artículo científico publicado en 2012

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

artículo científico publicado en 2015

Outcome of male breast cancer: a matched single-institution series

artículo científico publicado en 2014

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

artículo científico publicado en 2015

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

artículo científico publicado en 1995

Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.

artículo científico publicado en 1995

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

artículo científico publicado en 2018

Pharmacokinetics of anticancer agents in patients with impaired liver function

scientific article published on 01 January 1998

Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer

Picking the optimal endocrine adjuvant treatment for pre-menopausal women

artículo científico publicado en 2015

Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

artículo científico publicado en 1999

Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.

artículo científico publicado en 2014

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

artículo científico publicado en 2012

Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.

artículo científico publicado en 2004

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.

artículo científico publicado en 2017

Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial

artículo científico publicado en 2023

Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.

artículo científico publicado en 2016

Should liver metastases of breast cancer be biopsied to improve treatment choice? ⬇️

artículo científico publicado el 22 de febrero de 2011

Surgical resection margins after breast-conserving surgery: Senonetwork recommendations

artículo científico publicado en 2016

Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil

artículo científico publicado en 1998

Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Ex

article

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

artículo científico publicado en 2013

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

artículo científico publicado en 2013

Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

artículo científico publicado en 2018

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

artículo científico publicado en 2016

Unexpected Right Phrenic Nerve Injury During 5-Fluorouracil Continuous Infusion Plus Cisplatin and Vinorelbine in Breast Cancer Patients

artículo científico publicado en 2000

Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis

artículo científico publicado en 2016

Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy

artículo científico publicado en 1995

Lista de obras de Elisabetta Munzone

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?

Brain metastases in patients with advanced breast cancer

CMF revisited in the 21st century ⬇️

Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

Clinical overview of metronomic chemotherapy in breast cancer.

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.

Development and psychometric testing of a breast cancer patient-profiling questionnaire

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer.

Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.

Extended adjuvant chemotherapy in endocrine non-responsive disease

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)

Highlights from the ninth European breast cancer conference, glasgow, 19-21 march 2014

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

Metronomic therapy and breast cancer: a systematic review.

Metronomics in the neoadjuvant and adjuvant treatment of breast cancer

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

Mutations targeting the coagulation pathway are enriched in brain metastases.

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer

Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

Outcome of male breast cancer: a matched single-institution series

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project

Pharmacokinetics of anticancer agents in patients with impaired liver function

Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer

Picking the optimal endocrine adjuvant treatment for pre-menopausal women

Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.

Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial

Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.

Should liver metastases of breast cancer be biopsied to improve treatment choice? ⬇️

Surgical resection margins after breast-conserving surgery: Senonetwork recommendations

Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil

Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Ex

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

Unexpected Right Phrenic Nerve Injury During 5-Fluorouracil Continuous Infusion Plus Cisplatin and Vinorelbine in Breast Cancer Patients

Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis

Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy